NCT01287065View on ClinicalTrials.gov

A Study in Asthmatic Patients to Determine if There is Any Difference in Dosing With Fluticasone Furoate/Vilanterol Inhalation Powder in the Morning or Evening on Lung Function

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Asthma
Interventions
DRUG

FF(100mcg)/Vilanterol(25mcg) AM

Inhalation powder

DRUG

FF(100mcg)/Vilanterol(25mcg) PM

Inhalation powder

DRUG

Placebo AM

Inhalation powder

DRUG

Placebo PM

Inhalation powder

Trial Locations (1)

6021

GSK Investigational Site, Wellington

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01287065 - A Study in Asthmatic Patients to Determine if There is Any Difference in Dosing With Fluticasone Furoate/Vilanterol Inhalation Powder in the Morning or Evening on Lung Function | Biotech Hunter | Biotech Hunter